Italia markets closed

TEVA Jun 2024 17.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,03000,0000 (0,00%)
In data: 12:59PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,0300
Aperto1,0300
Denaro0,6600
Domanda3,2500
Prezzo d'esercizio17,50
Scadenza2024-06-28
Min-Max giorno1,0300 - 1,0300
Contratto - Min-MaxN/D
Volume2
Open Interest52
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.